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Abstract 
Dystrophic cardiac calcinosis (DCC), also called epicardial and myocardial fibrosis and mineralization, 
has been detected in mice of a number of laboratory inbred strains, most commonly C3H/HeJ and 
DBA/2J. In previous mouse breeding studies between these DCC susceptible and the DCC resistant 
strain C57BL/6J, 4 genetic loci harboring genes involved in DCC inheritance were identified and 
subsequently termed Dyscal loci 1 through 4. Here we report susceptibility to cardiac fibrosis, a sub-
phenotype of DCC, at 12 and 20 months of age and close to natural death in a survey of 28 inbred 
mouse strains. Eight strains showed cardiac fibrosis with highest frequency and severity in the 
moribund mice. Using genotype and phenotype information of the 28 investigated strains we performed 
genome-wide association studies (GWAS) and identified the most significant associations on 
chromosome (Chr) 15 at 72 million base pairs (Mb) (P < 10-13) and Chr 4 at 122 Mb (P < 10-11) and 
134 Mb (P < 10-7). At the Chr 15 locus Col22a1 and Kcnk9 were identified. Both have been reported to 
be morphologically and functionally important in the heart muscle. The strongest Chr 4 associations 
were located approximate 6 Mb away from the Dyscal 2 quantitative trait locus peak within the 
boundaries of the Extl1 gene and in close proximity to the Trim63 and Cap1 genes. In addition, a single 
nucleotide polymorphism association was found on chromosome 11. This study provides evidence for 
more than the previously reported 4 genetic loci determining cardiac fibrosis and DCC. The study also 
highlights the power of GWAS in the mouse for dissecting complex genetic traits.  
  
3	  
Introduction 
Dystrophic cardiac calcinosis (DCC), also known as epicardial and myocardial fibrosis and 
mineralization, has been reported for several inbred strains of mice, including C3H and DBA 
substrains, but not others, such as the most commonly used C57BL/6J mouse strain (Eaton et al. 1978; 
Firth and Ward 1988; Le Corre et al. 2012; Sundberg et al. 2014; Van Vleet and Ferrans 1987). This 
lesion has a variable presentation across many inbred strains in terms of severity, frequency, 
distribution, and ratio of fibrosis to mineralization. The most common presentation involves 
mineralization and fibrosis of the outermost layer of the right ventricular free wall of the heart, 
extending from the epicardium. The left ventricular free wall may also be involved but usually less 
severely. Focal lesions of various sizes may or may not occur throughout the myocardium. Crosses 
between C3H/HeJ and C57BL/6J mice identified 4 quantitative trait loci (QTL), designated as 
Dystrophic cardiac calcinosis 1 through 4 (Dyscalc1-4) (Ivandic et al. 2001). Similar studies were 
performed with DBA/2J and C57BL/6J crosses which identified similar genetic loci (Brunnert et al. 
1999). 
Mapping to mouse chromosome (Chr) 7 (Ivandic et al. 1996), Dyscalc1 was associated with the 
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 (Abcc6) gene (Aherrahrou et al. 2008; 
Meng et al. 2007). Mutations in this gene in humans and targeted genetic lesions in laboratory mice 
produce pseudoxanthoma elasticum (PXE), a multi-system disease manifesting with mineralization in 
the skin and vascular connective tissues (Li et al. 2016; Uitto et al. 2010). This observation in C3H 
substrains was extended to include the KK/HlJ and 129S1/SvImJ inbred strains in mouse aging studies, 
strains that have the same Abcc6 allelic mutation (Berndt et al. 2013). Severe lesions in the KK/HlJ 
strain, closely resembling those seen in Abcc6tm1Jfk and Abcc6tm1Aabb genetically engineered null mice 
(Gorgels et al. 2005; Klement et al. 2005), suggest that KK/HlJ mice may be an alternative spontaneous 
mouse model for studying PXE (Li et al. 2012). By contrast, another inbred mouse strain, 
129S1/SvImJ, carries the same Abcc6 allelic polymorphism but does not exhibit most of the PXE-like 
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lesions seen in KK/HlJ (Berndt et al. 2013), which raises the question of the percent of penetrance of 
the associated polymorphisms. Finally, additional modifier genes may be responsible for these 
phenotypic differences between strains. 
 As DCC has been considered a characteristic lesion for PXE in C3H and DBA substrains 
(strains with the same allelic mutations in their Abcc6 gene) (Le Corre et al. 2012), examining heart 
lesions across 28 inbred strains provides an alternative approach to identification of modifier genes, 
such as those included within the Dyscalc2-4 QTLs. Furthermore, while QTLs provide a genetic 
location in which to search for modifier genes, large scale, targeted mutant studies (knockout mice), in 
which the mutant mice have been carefully phenotyped histologically, provide additional candidates, 
especially when the mutant mice show features of mineralization similar to various degrees to that seen 
in the Abcc6 null mice (phenotypic mimics). Such genes in mice include: family with sequence 
similarity 20, member A and C (Fam20a and Fam20c) (Vogel et al. 2012), extracellular calcium-
sensing receptor (Casr) (Hough et al. 2004), ectonucleotide pyrophosphatase/phosphodiesterase1 
(Enpp1) (Li et al. 2014a; Li et al. 2013; Li et al. 2014b), klotho (Kl) (Hu et al. 2011), tripartite motif-
containing 24 (Trim24; formerly transcription 1 alpha, Tif1a) (Ignat et al. 2008), and others (Kornak 
2011; Li and Uitto 2013). These may be primary genes responsible for the phenotype or they may be 
integrated into one or more molecular pathways. Finally, single nucleotide polymorphisms (SNP) 
analyses, combined with literature review, can be an effective way to identify and begin to validate 
candidate genes. 
 While there is currently no single genetic approach to identify all the genes that induce, regulate 
progression, and ultimately cause lesions in various diseases, each method provides pieces of this 
complicated puzzle. Routine QTL mapping of F2 progeny for all traits of a disease generally results in 
large genetic intervals but identification of specific genes is often not successful, as was shown for 
various models of inflammatory bowel disease (Beckwith et al. 2005; Birkenmeier et al. 1995; Bristol 
et al. 2000; Farmer et al. 2001; Mahler et al. 1998; Mahler et al. 1999). However, combining QTL 
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mapping with analysis of sub-congenic mouse lines for lymphatic changes in inflammatory bowel 
disease resulted in the identification and validation of the specific genes responsible for that trait 
(Jurisic et al. 2010). An alternative approach to those described above is to use the genetic and 
phenotypic diversity among a large number of inbred strains in genome-wide association studies 
(GWAS). These unbiased population studies have been useful to identify genome variations 
responsible for airway hyper-responsiveness and pulmonary adenomas (Berndt et al. 2011a; Berndt et 
al. 2011b; Leme et al. 2010). 
 Here we performed population analysis for cardiac fibrosis in aged mice of 28 strains and 
identified novel candidate genes using a plethora of bioinformatics technologies, including GWAS. 
Genes identified are involved in initiation of disease to its ultimate outcome and severity indicating that 
these combined approaches can refine the molecular pathogenesis of cardiac fibrosis and serve as a 
template to similar investigations of other diseases.  
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Materials and methods 
Mice 
Aging study. Mice were obtained from a large-scale aging study performed at the Jackson Aging Center 
that has been described in detail elsewhere (Sundberg et al. 2011). The following 31 strains were 
examined in this present study: 129S1/SvImJ, A/J, AKR/J, BALB/cByJ, BTBRT+tf/J, BUB/BnJ, 
C3H/HeJ, C57BL/10J, C57BL/6J, C57BLKS/J, C57BR/cdJ, C57L/J, CAST/EiJ, CBA/J, DBA/2J, 
FVB/NJ, KK/HIJ, LP/J, MRL/MpJ, NOD.B10Sn-H2b/J (a congenic strain with the NOD genetic 
background but with a histocompatibility locus from a diabetes-resistant strain), NON/ShiLtJ, 
NZO/HlLtJ, NZW/LacJ, P/J, PL/J, PWD/PhJ, RIIIS/J, SJL/J, SM/J, SWR/J, and WSB/J. Three of the 
strains were not evaluated because of lymphoma development (AKR/J), lack of enough mice for 
analysis (CAST/EiJ), and self-mutilations resulting in euthanasia for humane purposes (SJL/J) 
(Sundberg et al. 2011). Therefore, analyses were performed in 28 strains of mice. Mice from several 
cross-sectional cohorts (at 12 and 20 months) and a longitudinal (close to natural death) cohort were 
evaluated for heart lesions. Fifteen females and 15 males for each strain entered the cross-sectional 
cohorts and 65 females and 35 males entered the longitudinal study group. Cross-sectional and 
longitudinal groups were set-up in parallel. Those mice that survived were euthanized by CO2 
asphyxiation, weighed, and underwent complete necropsies at the defined ages (Silva and Sundberg 
2012).  
 
Retired breeders. Ten female and 10 male mice were obtained from The Jackson Laboratory (Bar 
Harbor, ME) as retired breeders (i.e., 5-10 months of age depending on the rotation time for the 
colony)(Flurky et al. 2009) from the following 16 inbred strains: A/J, BALB/cByJ, BALB/cJ, 
C3H/HeJ, C57BL/6J, C57BL/10J, C57BR/cdJ, C57L/J, DBA/2J, FVB/NJ, KK/HlJ, LP/J, PWD/PhJ, 
SWR/J, MRL/MpJ-Faslpr/J, and SJL/J. Mice were euthanized by CO2 asphyxiation, weighed, and the 
hearts were removed and processed for histologic evaluation.  
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All protocols were reviewed and approved by The Jackson Laboratory Animal Care and Use 
Committee. Mouse handling and care were followed according to the Public Health Service animal 
welfare policies using IACUC approved methods. 
 
Tissue fixation and preparation 
Hearts in the aging study and retired breeder study were removed and fixed in Fekete’s acid-alcohol-
formalin solution for 12 hours then transferred to 70% ethanol, trimmed (in the four chamber 
longitudinal orientation), and processed routinely for histology. One and sometimes two serial sections 
were stained with hematoxylin and eosin (H&E). For the retired breeder study at least two hearts were 
sectioned in the four chamber longitudinal orientation (bisected, two sections per heart, two sets per 
slide) whereas the remainder were sectioned transversely at the equator, base, and apex (3 sections per 
heart, two sets per slide) (Chase et al. 2009). A third slide was stained with Masson’s Trichrome only 
for hearts obtained from retired breeders.  
 
Quantification of lesion severity 
Histology slides were reviewed by an experienced, board-certified veterinary pathologist (John P. 
Sundberg). Histological diagnosis of cardiac fibrosis was evaluated per strain and gender. The 
frequency and degree of epicardial mineralization and fibrosis, ventricular free wall atrophy, and 
ventricular fibrosis of the left and right heart were evaluated separately. The inter-ventricular septum 
and myocardium was also reviewed for lesions. The severity is based on a subjective measure of the 
size of the lesion (scores: 0 - normal; 1 - mild; 2 - moderate; 3 - severe; 4 - extreme). Selected cases 
were photographed to document the range in severity and are available on Pathbase 
(http://www.pathbase.net/). Cardiac fibrosis was also defined by frequency (percentage of mice 
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diagnosed with cardiac fibrosis per total number of mice per strain and gender). Data were recorded 
and coded using the Mouse Disease Information System (MoDis) (Sundberg et al. 2008).  
 
Histology 
Diagnosis of heart lesions, while evident at the time of necropsy, was confirmed by histopathology and 
graded based on extent and distribution. A number of the commonly used inbred strains, notably 
DBA/2J, C3H/HeJ, BALB/cJ, and BALB/cByJ, had various combinations of epicardial mineralization 
and fibrosis (primarily but not exclusively on the right ventricular free wall), which can also be 
scattered through the myocardium, a disease commonly referred to as DCC (Frith and Ward 1988). 
Whether the mineralization was the initiating event or a sequela to the fibrosis was not determined. 
However, ectopic mineralization, which can involve multiple other organs (Berndt et al. 2012), appears 
to be controlled by a number of other genes that complicate genetic interpretation of the mechanisms. 
As such, these processes were separated and fibrosis, independent of mineralization, was the focus of 
this investigation.  
 
Genome-wide association mapping and variant identification 
Phenotype-genotype association analysis was performed using the expedited efficient mixed-model 
association (EMMAX) algorithm (Kang et al. 2010). Frequencies and mean severities of the fibrosis 
phenotype in 28 strains of mice were used as input phenotype data. Four million SNPs (available at 
http://mouse.cs.ucla.edu/mousehapmap/full.html) were used as input genotype data. Each SNP was 
evaluated individually and recorded as –log(P-values) as the strength of the genotype-phenotype 
associations and graphically displayed in Manhattan plots. SNP effects were determined using the 
Variant Effect Predictor tool by Ensembl (http://useast.ensembl.org/info/docs/tools/vep/index.html). 
Coding region SNPs known to change the amino acid sequence (i.e., non-synonymous SNPs) were 
9	  
tested for functional importance using the PolyPhen-2 algorithm 
(http://genetics.bwh.harvard.edu/pph2/) (Adzhubei et al. 2010). 
 
Statistical analysis 
Frequencies and strain means ± SEM of phenotype severities were calculated separately for each age 
group by genders using JMP8 statistical analysis software (https://www.jmp.com/software/jmp8/). 
Fisher’s exact test was used to determine the difference in frequencies and the two-sided Kruskal-
Wallis nonparametric test was used to determine the differences in severity between males and females 
for each strain. The Kruskal-Wallis test is comparable to one-way analysis of variance, but without the 
parametric assumptions. All statistical computations were completed using SPSS version 15.0 software 
(SPSS Inc., Chicago, IL). 
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Results and discussion 
Cardiac fibrosis datasets - aging survey and retired breeders 
We had two independent datasets for age-related cardiac fibrosis phenotype in different strains of mice. 
The first was an aging study which was divided into a longitudinal or life span investigation (65 
females and 35 males each strain) and a cross-sectional study (15 females and 15 males each strain), to 
evaluate onset and diversity of diseases at 12 and 20 months of age on 28 inbred strains of mice. Mice 
in the longitudinal study were allowed to become moribund at which point they were euthanized by 
CO2 asphyxiation. All investigated strains were part of a large-scale aging study by the Jackson Aging 
Center which has been described in detail elsewhere (Sundberg et al. 2011). The second study was 
performed on mice of 16 inbred strains as retired breeders from the production facilities of The Jackson 
Laboratory. They are the retired mice at 5-10 months of age (10 females and 10 males each strain) 
depending on the rotation time for the colony. Cardiac tissues were collected and prepared from all the 
mice described above for histopathology for cardiac lesions. For detailed description of these two 
datasets, see Materials and methods section under “Mice”. 
 
Histology 
Cardiac fibrosis varied in severity and distribution between individuals and between strains with 
increasing fibrosis frequency and severity in older mice (Fig. 1). In general, cardiac fibrosis was 
diagnosed in the left and right ventricular wall, inter-ventricular septum, and myocardium to various 
degrees in inbred mouse strains (Frith and Ward 1988). These lesions are described in detail in mouse 
pathology textbooks (Frith and Ward 1988; Mohr et al. 1996) and many additional images from this 
study can be found online (http://www.pathbase.net/) (Schofield et al. 2010).  
The C57BL/10J strain has rarely been associated with heart lesions in the literature (Neu et al. 
1987), yet these mice had severe fibrosis of the right ventricular free wall usually, but not exclusively, 
without mineralization associated with severe atrophy of the cardiac muscle. Masson’s Trichrome 
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staining illustrated increased collagen deposition in hearts from C57BL/10J at 10 months of age 
compared to C57BL/6J at 8 months of age, which had little except around vessels as would be expected 
(Fig. 2). Retrospective review of our computerized medical records of disease surveillance in all strains 
since 1987 revealed that these heart changes, particularly the severe right ventricular fibrosis and 
atrophy, have been a feature of C57BL/10J since the time these records were collected.  
 
Frequency and severity of cardiac fibrosis 
Among the 28 mouse strains of the aging study, 8 strains (A/J, BALB/cByJ, C3H/HeJ, C57BL/10J, 
DBA/2J, KK/HlJ, NZO/H1LtJ and PL/J) developed cardiac fibrosis at different stages of the entire 
aging process (Table S1). While five strains (A/J, BALB/cByJ, C57BL/10J, DBA/2J and KK/HlJ) were 
affected in the 12 month group, 7 strains were affected in the 20 month group and in moribund mice. 
Most frequently, lesions were observed in moribund mice that were close to natural death of all strains 
(Table 1). Similarly, the severity of the lesions was strongest in the moribund mice of all strains (Table 
2). 
 Mice from the 16 retired breeder strains were obtained at 5 to 10 months of age. Mice of 7 
strains (A/J, BALB/cByJ, BALB/cJ, C3H/HeJ, C57BL/10J, DBA/2J and KK/HlJ) developed cardiac 
fibrosis (Table S2). C57BL/10J and DBA/2J mice had the highest severity scores among 16 retired 
breeder strains (Table 3). BALB/cByJ had a higher frequency of heart lesions than its closely related 
substrain, BALB/cJ. 
 
Genome-wide association mapping for cardiac fibrosis frequency and severity 
GWAS has been proven successful to identify causative genomic loci for a number of disease 
phenotypes. GWAS analysis excels traditional QTL studies because it utilizes denser SNP panels for 
identification of smaller genomic regions, which leads to fewer candidate genes for subsequent 
experimental verification. As part of the large-scale ageing study at the Jackson Ageing Center, 28 
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inbred mouse strains at 12 and 20 months of age develop various degrees of fibrosis in the heart, with 
respect to both frequency and severity. The large scale phenotype dataset and various degrees of 
phenotype allow us to identify genes associated with cardiac fibrosis frequency and severity by GWAS 
analysis. 
Phenotype-genotype association analysis was performed using the expedited efficient mixed-
model association (EMMAX) algorithm (Kang et al. 2010). Frequencies (for affected strains: Table 1) 
and mean severities (for affected strains: Table 2) of the fibrosis phenotype in 28 strains of mice were 
used as input phenotype data. Phenotypes from males and females were combined to increase the 
power for the genetic analysis. Four million SNPs were used as input genotype data. 
For the 12 month age group, strong associations with frequency (P = 1.1 x 10-11) and severity (P = 
1.5 x 10-10) of cardiac fibrosis were found on Chr 4 at 122,602,996 base pairs (bp) (Fig. 3A, frequency; 
Fig. 3B, severity). There were also strong associations on Chr 11 at 3,614,390 bp (frequency: P = 8.6 x 
10-9; severity: P = 8.6 x 10-11) and 46,911,030 bp (frequency: P = 1.2 x 10-8; severity: P = 1.3 x 10-10). 
While the region on Chr 4 was supported by 4 adjacent SNP associations, each locus on Chr 11 was a 
single SNP association.  
For the 20 month age group, left ventricular fibrosis was associated most significantly with 
frequency (P = 9.9 x 10-11) and severity (P = 5.5 x 10-13) on Chr 15 at 72,274,700 bp (Fig. 3C, 
frequency; Fig. 3D, severity). The Chrs 4 and 11 associations shown for the 12 month age group could 
also be detected in this 20 month age group; however, they were less significant. For frequency, the 
Chr 4 association had a P-value of 1.2 x 10-5 and the Chr 11 association at 3,614,390 bp showed a P-
value of 5.5 x 10-6. For severity, the strongest Chr 4 association was no longer located at about 122.6 
million base pairs (Mb) but at 134.4 Mb with as many as 12 SNPs in close proximity (P = 8.6 x 10-7). 
The Chr 11 associations at about 3.6 and 46.9 Mb showed P-values of 9.2 x 10-6 and 9.8 x 10-6, 
respectively. 
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Identification of candidate genes 
GWAS identified several new genome locations that potentially point to novel biomarkers determining 
the phenotypic variations in cardiac fibrosis. The phenotype-genotype association on Chr 4 at about 
122.6 Mb was located about 5 Mb proximal of the Dyscalc 2 QTL peak at 127.8 Mb. Cyclase-
associated protein 1 (Cap1) is located 250 Kb downstream of this SNP association. Interestingly, a 
recent investigation showed that the lack of Cap1’s isoform Cap2 leads to dilated cardiomyopathy 
(Peche et al. 2013). The Chr 4 association at about 134.4 Mb was located within close proximity of the 
Dyscalc 2 QTL peak. The SNP association was found to be located within the boundaries of the gene 
exostoses (multiple)-like 1 (Extl1). Some rare variants of multiple exostoses are associated with 
cardiomyopathy in humans (Atiq and Aziz 1997; Hamouda et al. 2011). 
Two other genes, solute carrier family 30 (zinc transporter), member 2 (Slc30a2) and tripartite 
motif-containing 63 (Trim63), are located approximately at 20 kb and 45 kb, respectively, upstream of 
the SNP associations and the gene platelet-activating factor acetylhydrolase 2 (Pafah2) is located about 
21 kb downstream. Interestingly, Trim63 has been associated with several human heart conditions, such 
as hypertrophic cardiomyopathy, chronic heart failure and aging metabolism, and cardiac 
ischemia/reperfusion injury (Chen et al. 2012). 
The phenotype-genotype association on Chr 15 at about 72.3 Mb is located about 400 kb 
upstream of collagen, type XXII, alpha 1 (Col22a1) and about 240 kb downstream of potassium 
channel, subfamily K, member 9 (Kcnk9, formerly Task3). Col22a1 is a part of tissue junctions and 
commonly found in skeletal and heart muscles (Koch et al. 2004). In addition, this was a noted 
candidate gene for isoproterenol induced cardiac fibrosis in a young mouse model (Rau et al. 2015). 
Immununofluorescence screening revealed that COL22A1 protein was expressed at the chordae 
tendineae insertion sites into the muscle of the right ventricle in adult C57BL/6J mice (data not shown), 
consistent with the tissue junction expression of this protein in postnatal mouse tissues, as previously 
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reported (Koch et al. 2004). Kcnk9 is differentially expressed in developing hearts where it contributes 
to the potassium conductance that is responsible for cardiac excitability (Kim et al. 2000).  
In a massive histopathological screening of all organ systems in 28 inbred strains of mice of 
both genders (Sundberg et al. 2011), dystrophic cardiac calcinosis was diagnosed in 8 strains. Within 
the affected mice, a subgroup had areas of fibrosis without mineralization. Lesions varied in severity 
and location within the hearts between the strains. Genome-wide association mapping of cardiac 
fibrosis determined that none of the QTLs previously identified for DCC, in which mineralization is a 
major feature, corresponded to any identified loci. The same was true for fibro-osseous lesions, another 
pathological process found in strains that exhibit mineralization and fibrotic lesions in bones and other 
organs (e.g., skin) including C3H/HeJ (Berndt et al. 2016). 
 While it is relatively easy to see clinical correlations between seemingly unrelated diseases with 
small numbers of mice undergoing experimental manipulation, it is critically important to understand 
strain-specific background lesions before drawing conclusions. The mineralization phenomena among 
inbred strains are very complicated. Some of the phenotypic observations are related to each other due 
to shared genetic predispositions. However, the underlying genetic basis can be modified by genes 
involved in other diseases which add to the complexity of the predisposition. Such appears to be the 
case for Abcc6 and ectopic mineralization (Berndt et al. 2013). There have been correlations to a 
specific SNP in the Abcc6 gene in C3H/HeJ, DBA/2J, and KK/HlJ mice that get ectopic mineralization 
and DCC and in 129S1/SvImJ, which gets ectopic mineralization but not the heart lesions (Berndt et al. 
2013). However, BALB/cJ, BALB/cByJ, C57BL/10J and A/J also develop these heart lesions, but do 
not exhibit this genomic variation in Abcc6. Therefore, these results suggest that Abcc6 is rather a 
modifier gene for the complex PXE phenotype and not the primary cause of heart lesions. Evaluation 
of the Sanger mouse SNP database (http://www.sanger.ac.uk/cgi-
bin/modelorgs/mousegenomes/snps.pl) reveals that A/J and BALB/cByJ have three non-synonymous 
coding SNPs in Abcc6, which are not found in the other strains (positions at 53,232,273 bp, 53,232,660 
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bp, and 53,274,055 bp). These SNPs presumably could have an effect on the phenotype thereby 
suggesting that these mice are additional models for PXE. The organ specificity observed for the 
mineralization/fibrosis syndrome may potentially represent individual diseases altogether due to the 
complex genetic background of each trait as shown here.  
In a mouse cardiac ischemia-reperfusion model, investigators found that genetically engineered 
C57BL/6 mice with a null mutation in Abcc6 had larger infarcts than wild type controls. Conversely, 
transgenic mice expressing wildtype Abcc6 in C3H/HeJ, which are naturally hypomorphic for Abcc6, 
had reduced infarct size compared to C3H/HeJ mice without the transgene suggesting that ABCC6 was 
a novel modulator of cardiac myocyte survival after injury (Mungrue et al. 2011). A study using 23 
inbred mouse strains using beta-adrenergic cardiac blockade or stimulation found a great deal of 
variability between the strains (Berthonneche et al. 2009). Another study utilized over 100 inbred and 
recombinant inbred strains, including 25 of the 28 studied here. Female mice, 8-10 weeks of age were 
treated with isoproterenol (ISO) for 21 days (total age 11-13 weeks) and hearts evaluated for cardiac 
fibrosis and mineralization. Mice in this induced model had GWAS performed and while they found 
over 24 candidate loci, each containing an average of 14 genes, they focused on Abcc6. Using targeted 
Abcc6 mutant and KK/HlJ mice they concluded that ”the age-associated calcification phenotype 
observed in Abcc6 KO is distinct from the ISO-induced cardiac fibrosis phenotype” (Rau et al. 2015). 
These findings confirm that Abcc6 is involved with some aspects of myocardial health and response to 
injury and aging, but it is one of many genes and not likely, in and of itself, to be the primary cause of 
DCC. They also note Col22a1 as a highlighted gene, one of 6 in the ISO treated fibrosis intervals on 
Chr 15 (Rau et al. 2015). Col22a1 was a major candidate gene in the study reported here for age 
associated cardiac fibrosis suggesting this protein may play an important role in myocardial fibrosis 
induced by a variety of different types of insults to the heart.  
 Non-synonymous SNPs in the Abcc6 gene are considered to account for the Dyscalc1 QTL 
(Aherrahrou et al. 2008; Meng et al. 2007). Although 5 Mb distal, Dyscalc2 may involve identified 
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variants in Cap1, Extl1, Slc20a2, Pafah2, but especially Trim63 as this gene is associated with some 
types of heart disease (Chen et al. 2012). No candidate genes were identified in this GWAS to account 
for the Dyscalc3 or 4 QTLs. However, Col22a1 and Kcnk9 on Chr 15 appear to be important and 
demonstrate that when many strains are evaluated it is possible to find new genes (or at least genomic 
regions) while losing significance for others presumably because of dilution of the signal through the 
broader genomic variety when performing strain surveys compared to two strain QTL crosses. This and 
many other complex genetic traits have to be evaluated by many approaches, such as crosses between 
inbred strains in the earliest studies (Brunnert et al. 1999; Ivandic et al. 2001), GWAS analyses for as 
many strains as possible (as in the current studies), to large scale targeted mutagenesis of genes for 
which little is currently known, as was done by the Lexicon phenotyping program (Hough et al. 2004; 
Schofield et al. 2012; Vogel et al. 2012) or as is currently being done in the KOMP2 project (Brown et 
al. 2007; DiTommaso et al. 2015). There is no single approach to address all aspects of a complex 
genetic disease. Furthermore, comparing and contrasting similar diseases between species, as with 
humans and mice in this case, combined with new discoveries on the genetics and pathophysiology will 
continue to unravel the complexities of many common diseases that affect all mammalian species.  
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Table 1. Frequency of cardiac fibrosis phenotype in 8 affected strains of mice in the aging study 
Affected 
strains	  
12 mo	   20 mo	   Moribund	  
F	   M	   F	   M	   F	   M	  
A/J	   3/14 (21.4)	   2/13 (15.4)	   4/7 (57.1)	   1/9 (11.1)	   15/19 (78.9)	   5/10 (50.0)	  
BALB/cByJ	   2/14 (14.3)	   3/14 (21.4)	   5/15 (33.3)	   6/9 (66.7)	   6/12 (50.0)	   3/4 (75.0)	  
C3H/HeJ	   0/9 (0)	   0/14 (0)	   0/6 (0)	   1/10 (10.0)	   2/13 (15.4)	   2/5 (40.0)	  
C57BL/10J	   3/14 (21.4)	   4/14 (28.6)	   7/12 (58.3)	   5/14 (35.7)	   2/4 (50.0)	   4/7 (57.1)	  
DBA/2J	   10/12 (83.3)	   10/11 (90.9)	   4/7 (57.1)	   5/6 (83.3)	   5/5 (100.0)	   6/7 (85.7)	  
KK/HlJ	   11/15 (73.3)	   9/12 (75.0)	   6/7 (85.7)	   3/7 (42.9)	   2/4 (50.0)	   2/3 (66.7)	  
NZO/HlLtJ	   0/12 (0)	   0/5 (0)	   0/6 (0)	   1/5 (20.0)	   NA	   0/2 (0)	  
PL/J	   0/9 (0)	   0/14 (0)	   0/5 (0)	   0/2 (0)	   1/1 (100.0)	   0/1 (0)	  
NA, no mice were examined for the strain. F, female; M, male. 
Values were expressed as the number of affected mice by the total number of mice, and the percent of affected 
animals per strain and gender. 
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Table 2. Severity of cardiac fibrosis phenotype in 8 affected strains of mice in the aging study 
Affected 
strains	  
12 mo	   20 mo	   Moribund	  
F	   M	   F	   M	   F	   M	  
A/J	   0.43±0.25	   0.23±0.17	   0.71±0.29	   0.10±0.11*	   1.58±0.25	   0.80±0.33	  
BALB/cByJ	   0.36±0.25	   0.21±0.11	   1.00±0.39	   1.89±0.51	   1.17±0.42	   1.75±0.85	  
C3H/HeJ	   0	   0	   0	   0.10±0.11	   0.15±0.15	   0.60±0.40	  
C57BL/10J	   0.64±0.34	   0.50±0.25	   1.17±0.32	   0.71±0.30	   0.50±0.29	   1.43±0.69	  
DBA/2J	   3.00±0.43	   3.36±0.36	   0.57±0.20	   2.67±0.67**	   3.40±0.25	   3.14±0.63	  
KK/HlJ	   2.13±0.41	   1.42±0.36	   2.29±0.61	   0.86±0.46	   1.50±0.96	   1.00±0.58	  
NZO/HlLtJ	   0	   0	   0	   0.40±0.40	   NA	   0	  
PL/J	   0	   0	   0	   0	   2.00	   0	  
The scoring of cardiac fibrosis was based on a subjective measure of the size of the lesion by an experienced, 
board-certified veterinary pathologist (JPS). NA, no mice were examined for the strain. F, female; M, male. 
Severity of scores: 0, normal; 1, mild; 2, moderate; 3, severe; 4, extreme. Values were expressed as mean score ±	  
SEM. *P < 0.05, **P < 0.01 vs. females for the same strain at the same age. 	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Table 3. Frequency and severity of cardiac fibrosis phenotype in 7 affected retired breeder strains of mice  
Affected 
strains	  
Frequency	   Severity	  
F	   M	   F	   M	  
A/J	   6/10 (60.0)	   2/10 (20.0)	   1.20±0.36	   0.20±0.13*	  
BALB/cByJ	   8/10 (80.0)	   8/10 (80.0)	   1.40±0.31	   1.80±0.39	  
BALB/cJ	   5/10 (50.0)	   3/10 (30.0)	   0.50±0.17	   0.30±0.15	  
C3H/HeJ	   10/10 (100.0)	   6/10 (60.0)	   1.50±0.22	   1.20±0.39	  
C57BL/10J	   10/10 (100.0)	   10/10 (100.0)	   2.90±0.18	   2.60±0.22	  
DBA/2J	   10/10 (100.0)	   8/10 (80.0)	   3.00±0.33	   2.00±0.39	  
KK/HlJ	   10/10 (100.0)	   8/10 (80.0)	   2.50±0.34	   1.40±0.34*	  
The frequency of cardiac fibrosis was expressed as the number of affected mice by the total number of mice and 
percent of affected animals. The scoring of cardiac fibrosis was based on a subjective measure of the size of the 
lesion by an experienced, board-certified veterinary pathologist (JPS). Severity of scores were expressed as mean 
score ±	  SEM. 0, normal; 1, mild; 2, moderate; 3, severe; 4, extreme. F, female; M, male. * P < 0.05 vs. females 
for the same strain. 
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Figure Legend 
Figure 1. Heart lesions among inbred strains of mice. Focal myocardial fibrosis and mineralization 
(A-D, C3H/HeJ), right ventricular wall epicardial mineralization and fibrosis (E-H, BALB/cByJ; I-L, 
KK/HlJ), and right and left ventricular wall atrophy and fibrosis (M-P, C57BL/10J) represent the 
variety of changes observed in the heart. Arrows indicate areas of mineralization. The top two rows 
have hearts are stained with hematoxylin and eosin (H&E). The second row is a series of enlargements 
of the boxed areas in image above it. The bottom two rows are stained with Masson’s Trichrome to 
label collagen deposition (blue stained areas). 	  
 	  
Figure 2. Comparison of hearts in female C57BL6/J and C57BL/10J mice 8 and 10 months of 
age, respectively. The top panel (C57BL/6J; A, H&E; B, Masson’s Trichrome) is a normal heart with a 
small focus of mineralization in the left ventricle in the Masson’s stained section. Boxed areas are 
enlarged as indicated with arrows for detail. The lower panel (C57BL/10J; C, H&E; D, Masson’s 
Trichrome) reveals severe cardiac fibrosis primarily in the right ventricular wall but also throughout the 
left ventricle. Trichrome staining shows increased collagen deposition (blue stained areas). The right 
ventricular wall is completely replaced by fibrous connective tissue in multiple areas. 	  
 
Figure 3. Genome-wide association scan for frequency (A) and severity (B) of cardiac fibrosis in 
12 month old mice, and for frequency (C) and severity (D) of cardiac fibrosis in 20 month old 
mice. The SNPs with the highest Lod scores in chromosomes 4, 11 and 15 are indicated by circling. 
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Table S1 Subclassified cardiac fibrosis phenotype in 8 affected strains of mice in the aging study 
Affected 
strains	   Age (mo)	   Sex	  
No. of 
mice 
exami
ned	  
Phenot
ype	  
Right heart	   Left heart	  
IVS	   Myocardial 
MF	  
Epicardial MF	   VFW atrophy	   Vent 
fibrosis	  
Epicardial 
MF	  
VFW 
atrophy	  
Vent fibrosis	  
A/J	   12	   F	   14	   Freq	   3/14 (21.4)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.43±0.25	   0	   0	   0	   0	   0	   0	   0	  
 12	   M	   13	   Freq	   1/13 (7.7)	   0	   0	   0	   0	   0	   1/13 (7.7)	   0	  
    Seve	   0.08±0.08	   0	   0	   0	   0	   0	   0.15±0.15	   0	  
 20	   F	   7	   Freq	   4/7 (57.1)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.71±0.29	   0	   0	   0	   0	   0	   0	   0	  
 20	   M	   9	   Freq	   1/9 (11.1)	   0	   0	   0	   0	   1/7 (14.3)	   0	   0	  
    Seve	   0.11±0.11	   0	   0	   0	   0	   0.14±0.14	   0	   0	  
 Moribund	   F	   19	   Freq	   15/19 (79.0)	   4/7 (57.1)	   0	   4/7 (57.1)	   4/7 (57.1)	   4/7 (57.1)	   4/7 (57.1)	   0	  
    Seve	   1.58±0.25	   0.16±0.12	   0	   0.16±0.09	   0.16±0.12	   0.11±0.07	   0.16±0.09	   0	  
 Moribund	   M	   10	   Freq	   5/10 (50.0)	   1/10 (10.0)	   0	   0	   0	   0	   0	   0	  
    Seve	   0.80±0.33	   0.30±0.30	   0	   0	   0	   0	   0	   0	  
BALB/cByJ	   12	   F	   14	   Freq	   2/14 (14.3)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.36±0.25	   0	   0	   0	   0	   0	   0	   0	  
 12	   M	   14	   Freq	   3/14 (21.4)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.21±0.11	   0	   0	   0	   0	   0	   0	   0	  
 20	   F	   15	   Freq	   5/15(33.3)	   0	   0	   1/15 (6.7)	   0	   0	   0	   0	  
    Seve	   1.00±0.39	   0	   0	   0.13±0.13	   0	   0	   0	   0	  
 20	   M	   9	   Freq	   6/9 (66.7)	   0	   0	   1/9 (11.1)	   0	   0	   1/9 (11.1)	   0	  
    Seve	   1.89±0.51	   0	   0	   0.11±0.11	   0	   0	   0.11±0.11	   0	  
 Moribund	   F	   12	   Freq	   6/12 (50.0)	   0	   0	   1/12 (8.3)	   0	   0	   0	   0	  
    Seve	   1.17±0.42	   0	   0	   0.08±0.08	   0	   0	   0	   0	  
2	  
 Moribund	   M	   4	   Freq	   3/4 (75.0)	   1/4 (25.0)	   0	   0	   0	   0	   0	   0	  
    Seve	   1.75±0.85	   0.25±0.25	   0	   0	   0	   0	   0	   0	  
C3H/HeJ	   12	   F	   9	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 12	   M	   14	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   F	   6	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   M	   10	   Freq	   0	   0	   0	   0	   0	   0	   1/10 (10.0)	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0.10±0.10	   0	  
 Moribund	   F	   13	   Freq	   1/13 (7.7)	   0	   0	   0	   0	   0	   1/13 (7.7)	   0	  
    Seve	   0.08±0.08	   0	   0	   0	   0	   0	   0.08±0.08	   0	  
 Moribund	   M	   5	   Freq	   1/5 (20.0)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.40±0.40	   0	   0	   0	   0	   0	   0	   0	  
C57BL/10J	   12	   F	   14	   Freq	   3/14 (21.4)	   14/14 (100.0)	   0	   0	   0	   0	   0	   0	  
    Seve	   0.64±0.34	   2.14±0.25	   0	   0	   0	   0	   0	   0	  
 12	   M	   14	   Freq	   1/14 (7.1)	   11/14 (78.6)	   0	   0	   0	   4/14 (28.6)	   0	   0	  
    Seve	   0.21±0.21	   1.86±0.36	   0	   0	   0	   0.36±0.17	   0	   0	  
 20	   F	   12	   Freq	   5/12 (41.7)	   10/12 (83.3)	   0	   1/12 (8.3)	   0	   1/12 (8.3)	   1/12 (8.3)	   0	  
    Seve	   0.83±0.32	   2.17±0.37	   0	   0.08±0.08	   0	   0.33±0.22	   0.08±0.08	   0	  
 20	   M	   14	   Freq	   5/14 (35.7)	   11/14 (78.6)	   0	   1/14 (7.1)	   0	   2/14 (14.3)	   0	   0	  
    Seve	   0.57±0.25	   1.93±0.41	   0	   0.21±0.21	   0	   0.21±0.15	   0	   0	  
 Moribund	   F	   4	   Freq	   2/4 (50.0)	   4/4 (100.0)	   0	   0	   1/4 (25.0)	   0	   0	   0	  
    Seve	   0.50±0.29	   2.50±0.29	   0	   0	   0.25±0.25	   0	   0	   0	  
 Moribund	   M	   7	   Freq	   1/7 (14.3)	   6/7 (85.7)	   0	   3/7 (42.9)	   2/7 (28.6)	   3/7 (42.9)	   0	   0	  
3	  
    Seve	   0.14±0.14	   2.86±0.59	   0	   1.29±0.71	   0.43±0.30	   1.29±0.71	   0	   0	  
DBA/2J	   12	   F	   12	   Freq	   10/12 (83.3)	   0	   0	   1/12 (8.3)	   0	   0	   0	   0	  
    Seve	   3.00±0.43	   0	   0	   0.08±0.08	   0	   0	   0	   0	  
 12	   M	   11	   Freq	   10/11 (90.9)	   1/11(9.1)	   0	   0	   0	   0	   1/11(9.1)	   0	  
    Seve	   3.36±0.36	   0.18±0.18	   0	   0	   0	   0	   0.09±0.09	   0	  
 20	   F	   7	   Freq	   1/7 (14.3)	   0	   0	   0	   0	   0	   4/7 (57.1)	   0	  
    Seve	   0.14±0.14	   0	   0	   0	   0	   0	   0.57±0.20	   0	  
 20	   M	   6	   Freq	   4/6 (66.7)	   0	   0	   0	   0	   1/6 (16.7)	   3/6 (50.0)	   0	  
    Seve	   2.17±0.83	   0	   0	   0	   0	   0.33±0.33	   0.83±0.40	   0	  
 Moribund	   F	   5	   Freq	   5/5 (100.0)	   0	   0	   3/5 (60.0)	   0	   4/5 (80.0)	   3/5 (60.0)	   0	  
    Seve	   3.40±0.24	   0	   0	   0.80±0.37	   0	   1.60±0.40	   1.20±0.49	   0	  
 Moribund	   M	   7	   Freq	   6/7 (85.7)	   1/7 (14.3)	   0	   0	   0	   4/7 (57.1)	   5/7 (71.4)	   0	  
    Seve	   2.86±0.70	   0.29±0.29	   0	   0	   0	   1.00±0.38	   1.57±0.43	   0	  
KK/HlJ	   12	   F	   15	   Freq	   12/15 (80.0)	   0	   0	   0	   0	   0	   0	   6/15 (40.0)	  
    Seve	   2.33±0.39	   0	   0	   0	   0	   0	   0	   0.40±0.13	  
 12	   M	   12	   Freq	   9/12 (75.0)	   0	   0	   0	   0	   0	   0	   4/12 (33.3)	  
    Seve	   1.42±0.36	   0	   0	   0	   0	   0	   0	   0.33±0.14	  
 20	   F	   7	   Freq	   6/7 (85.7)	   0	   0	   0	   0	   1/7 (14.3)	   3/7 (42.9)	   3/7 (42.9)	  
    Seve	   2.29±0.61	   0	   0	   0	   0	   0.14±0.14	   0.43±0.20	   0.43±0.20	  
 20	   M	   7	   Freq	   3/7 (42.9)	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0.86±0.46	   0	   0	   0	   0	   0	   0	   0	  
 Moribund	   F	   4	   Freq	   1/4 (25.0)	   0	   0	   0	   0	   0	   1/4 (25.0)	   2/4 (50.0)	  
    Seve	   1.00±1.00	   0	   0	   0	   0	   0	   0.50±0.50	   0.50±0.29	  
 Moribund	   M	   3	   Freq	   2/3 (66.7)	   0	   0	   0	   0	   1/3 (33.3)	   0	   1/3 (33.3)	  
    Seve	   1.00±0.58	   0	   0	   0	   0	   0.67±0.67	   0	   0.33±0.33	  
4	  
NZO/HlLtJ	   12	   F	   12	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 12	   M	   5	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   F	   6	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   M	   5	   Freq	   0	   0	   0	   0	   0	   1/5 (20.0)	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0.40±0.40	   0	   0	  
 Moribund	   F	   NA	            
 Moribund	   M	   2	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
PL/J	   12	   F	   9	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 12	   M	   14	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   F	   5	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 20	   M	   2	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 Moribund	   F	   1	   Freq	   0	   0	   0	   0	   0	   1/1 (100.0)	   1/1 (100.0)	   0	  
    Seve	   0	   0	   0	   0	   0	   2.00	   2.00	   0	  
 Moribund	   M	   1	   Freq	   0	   0	   0	   0	   0	   0	   0	   0	  
    Seve	   0	   0	   0	   0	   0	   0	   0	   0	  
 
The 8 above mentioned strains of mice from the 28 strain survey developed cardiac fibrosis while others did not. 
The frequency of cardiac fibrosis was expressed as the percent of affected animals per strain and gender. F, 
female; M, male; Freq, Frequency; Seve, Severity; Epicardial MF, epicardial mineralization and fibrosis; VFW 
5	  
atrophy, ventricular free wall atrophy; Vent fibrosis, ventricular fibrosis; IVS, inter-ventricular septum; 
Myocardial MF, myocardial mineralization and fibrosis. 
 
 
6	  
 
Table S2. Subclassified cardiac fibrosis phenotype in 7 retired breeder strains of mice  
Affected 
strains	   Sex	   Phenotype	  
Right heart	   Left heart	  
Myocardial 
MF	  Epicardial 
MF	  
VFW atrophy	   Vent 
fibrosis	  
Epicardial 
MF	  
VFW 
atrophy	  
Vent 
fibrosis	  
A/J	   F	   Frequency	   60	   0	   0	   0	   0	   0	   0	  
  Severity	   1.20±0.36	   0	   0	   0	   0	   0	   0	  
 M	   Frequency	   20	   0	   0	   0	   0	   0	   0	  
  Severity	   0.20±0.13	   0	   0	   0	   0	   0	   0	  
BALB/cByJ	   F	   Frequency	   80	   10	   10	   20	   0	   0	   0	  
  Severity	   1.40±0.31	   0.20±0.20	   0.10±0.10	   0.20±0.13	   0	   0	   0	  
 M	   Frequency	   80	   10	   0	   0	   0	   0	   0	  
  Severity	   1.80±0.39	   0.10±0.10	   0	   0	   0	   0	   0	  
BALB/cJ	   F	   Frequency	   50	   0	   0	   0	   0	   0	   0	  
  Severity	   0.50±0.17	   0	   0	   0	   0	   0	   0	  
 M	   Frequency	   30	   0	   0	   0	   0	   0	   0	  
  Severity	   0.30±0.15	   0	   0	   0	   0	   0	   0	  
C3H/HeJ	   F	   Frequency	   40	   0	   0	   0	   0	   0	   100	  
  Severity	   0.70±0.33	   0	   0	   0	   0	   0	   1.60±0.22	  
 M	   Frequency	   40	   0	   0	   0	   0	   0	   30	  
  Severity	   1.00±0.42	   0	   0	   0	   0	   0	   0.30±0.15	  
C57BL/10J	   F	   Frequency	   60	   100	   100	   10	   100	   100	   0	  
  Severity	   1.50±0.48	   2.90±0.28	   2.50±0.17	   0.20±0.20	   1.20±0.20	   1.70±0.21	   0	  
 M	   Frequency	   60	   100	   100	   10	   100	   100	   0	  
  Severity	   1.00±0.33	   2.80±0.29	   2.40±0.22	   0.30±0.30	   1.70±0.30	   2.00±0.26	   0	  
7	  
DBA/2J	   F	   Frequency	   80	   0	   0	   10	   0	   10	   100	  
  Severity	   2.70±0.50	   0	   0	   0.20±0.20	   0	   0.10±0.10	   1.50±0.17	  
 M	   Frequency	   80	   0	   0	   0	   0	   0	   0	  
  Severity	   2.00±0.39	   0	   0	   0	   0	   0	   0	  
KK/HlJ	   F	   Frequency	   80	   0	   0	   0	   0	   0	   100	  
  Severity	   2.20±0.47	   0	   0	   0	   0	   0	   1.60±0.16	  
 M	   Frequency	   80	   0	   0	   0	   0	   0	   20	  
  Severity	   1.50±0.34	   0	   0	   0	   0	   0	   0.20±0.13	  
 
The above mentioned 7 strains of mice from the 16 retired breeder survey developed cardiac fibrosis while 
others did not. Ten female and ten male mice were examined for each strain. The frequency of cardiac fibrosis 
was expressed as the percent of affected animals. Severity of scores were expressed as mean score ±	  SEM. F, 
female; M, male; Epicardial MF, epicardial mineralization and fibrosis; VFW atrophy, ventricular free wall 
atrophy; Vent fibrosis, ventricular fibrosis; Myocardial MF, myocardial mineralization and fibrosis. None of the 
mice examined had fibrosis in the inter-ventricular septum. 
 
 
